The purpose of this study is to learn more about the effectiveness of first- and second-stage therapies for insomnia among individuals who have insomnia alone or in combination with a coexisting psychiatric disorder.
If you decide to enroll this study your participation will last for 16 months, the following things will happen:
- Initial screening evaluation visit.
- Maintain a sleep diary.
- For those who qualify, 6 to 12 weeks of insomnia treatment.
- Undergo sleep study.
- 4 follow-up visits.
Download the flyer for information on this clinical trial.